Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma-Reference-Cited by-同舟云学术

Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma

Published:2021-01-05 Issue:2 Volume:56 Page:125-132
ISSN:0192-0790
Container-title:Journal of Clinical Gastroenterology
language:en
Short-container-title:

Author:

Thota Prashanthi N.,Alkhayyat Motasem,Gomez Cifuentes Juan D.,Haider Mahnur,Bena James,McMichael John,Sohal Davender P.,Raja Siva,Sanaka Madhusudhan R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference36 articles.

1. Trends in esophageal cancer survival in United States adults from 1973 to 2009: a SEER database analysis;Njei;J Gastroenterol Hepatol,2016

2. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice;Rice;Ann Cardiothorac Surg,2017

3. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging;Amin;CA Cancer J Clin,2017

4. Staging of esophageal carcinoma in a low-volume EUS center compared with reported results from high-volume centers;van Vliet;Gastrointest Endosc,2006

5. Observer variation and reproducibility of endoscopic ultrasonography;Catalano;Gastrointest Endosc,1995

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of lymph node metastasis in T1 esophageal adenocarcinoma: a meta-analysis;Diseases of the Esophagus;2024-02-22

2. Sex differences in cancer-specific survival for locally advanced esophageal cancer after neoadjuvant chemoradiotherapy: A population-based analysis;Frontiers in Surgery;2022-07-29